Standout Papers
Citation Impact
Citing Papers
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications
2010
Cationic Poly- l -lysine Dendrimers: Pharmacokinetics, Biodistribution, and Evidence for Metabolism and Bioresorption after Intravenous Administration to Rats
2006
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
The European Physiotherapy Guideline for Parkinson’s Disease: Implications for Neurologists
2018
A catalogue of reporting guidelines for health research
2009
Roles of tau protein in health and disease
2017
Origins and Divergence of the Roma (Gypsies)
2001 Standout
Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: Effects of 12-month stimulation
2011
Referring Parkinson’s disease patients for deep brain stimulation: a RAND/UCLA appropriateness study
2015
Antiepileptic drugs: indications other than epilepsy
2004
Comparison of acceleration signals of simulated and real-world backward falls
2010
A tool to improve pre-selection for deep brain stimulation in patients with Parkinson’s disease
2010
Engineering precision nanoparticles for drug delivery
2020 Standout
Use and interpretation of on/off diaries in Parkinson's disease
2004
Deep brain stimulation for Parkinson's disease: disrupting the disruption
2002
Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses
2018 StandoutNobel
Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease<subtitle>A Randomized Controlled Trial</subtitle>
2009
Deep Brain Stimulation for Parkinson’s Disease
2008
Patient-centered integrated healthcare improves quality of life in Parkinson’s disease patients: a randomized controlled trial
2018
An optical neural interface:in vivocontrol of rodent motor cortex with integrated fiberoptic and optogenetic technology
2007
Analysis of Complications of Radiofrequency Pallidotomy
2003
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018
Parkinson's disease
2021 Standout
Parkinson's Disease
1998
Paraquat and Parkinson's disease
2010
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Non-recognition of depression and other non-motor symptoms in Parkinson's disease
2002
Ibuprofen-like activity in extra-virgin olive oil
2005 StandoutNature
The link between the GBA gene and parkinsonism
2012
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
2007
Pallidotomy for Parkinson disease: a review of contemporary literature
2001
The role of autophagy in neurodegenerative disease
2013 Standout
Nanoparticles: Oral Delivery for Protein and Peptide Drugs
2019
Transplantation in Parkinson’s Disease
2007
Alzheimer's disease
2011 Standout
Does the ADL part of the unified Parkinson's disease rating scale measure ADL? An evaluation in patients after pallidotomy and thalamic deep brain stimulation
2002
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Mild Cognitive Impairment
2011 Standout
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
2012
Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care
2020
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression
2017
Frequency and course of mild cognitive impairment in a multiethnic community
2008
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
2014 Standout
Parkinson's disease
2009 Standout
Bilateral simultaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects
1999
Organization and Evolution of Brain Lipidome Revealed by Large-Scale Analysis of Human, Chimpanzee, Macaque, and Mouse Tissues
2015 StandoutNobel
The impact of deep brain stimulation on executive function in Parkinson's disease
2000
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Parkinson's disease
2015 Standout
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
2014
Stereotactic Neurosurgery for Movement Disorders
2003
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
The neuropathology of genetic Parkinson's disease
2012
Deep brain stimulation for Parkinsonʼs disease and other movement disorders
2013
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
New practice parameters in Parkinson's disease
2006
Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus
2001
Long‐term efficacy of thalamic deep brain stimulation for tremor: Double‐blind assessments
2002
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
2013
Neurotoxic in vivo models of Parkinson’s disease
2010
State of Telehealth
2016 Standout
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
1996 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
2007
Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease
2002
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
1998
Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review
2016
Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease
2015
Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with α‐synuclein genotype
2009
Longitudinal Assessment of Neurocognitive Function after Coronary-Artery Bypass Surgery
2001 Standout
SURGERY FOR MOVEMENT DISORDERS
2008
Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review
2014
Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias?
2004
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review
1998
Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis
1997 StandoutNobel
End-to-end design of wearable sensors
2022 Standout
Deep-Brain Stimulation for Parkinson's Disease
2012
Solvent exposures and parkinson disease risk in twins
2011
Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease
1998
Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
2013
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
2007
Risk factors for amyotrophic lateral sclerosis
2015
Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease
2014
The molecular neurobiology of depression
2008 StandoutNature
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
2011
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
2009 StandoutNature
Thalamic Surgery and Tremor
2008
Long‐Term follow‐up of globus pallidus chronic stimulation in advanced Parkinson's disease
2002
The In Vivo Fate of Hydroxytyrosol and Tyrosol, Antioxidant Phenolic Constituents of Olive Oil, after Intravenous and Oral Dosing of Labeled Compounds to Rats
2001
Parkinson's disease subtypes: lost in translation?
2012
Parkinson's Disease
2003 Standout
Delirium in Mechanically Ventilated Patients
2001 Standout
Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
2012
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Interdisciplinary Home Visits for Individuals with Advanced Parkinson's Disease and Related Disorders
2018
Associations of welding and manganese exposure with Parkinson disease
2012
Metabolic correlates of levodopa response in Parkinson’s disease
2001
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Pharmacological Treatment of Parkinson Disease
2014
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
2011
Enantioselective Synthesis of Spirobarbiturate-Cyclohexenes through Phosphine-Catalyzed Asymmetric [4 + 2] Annulation of Barbiturate-Derived Alkenes with Allenoates
2016
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
1992 Standout
Focused ultrasound thalamotomy in Parkinson disease
2018
Nonviral Vectors for Gene Delivery
2008 Standout
Phosphine Organocatalysis
2018 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy
2011
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Carbonic Anhydrase Inhibitors: X-ray and Molecular Modeling Study for the Interaction of a Fluorescent Antitumor Sulfonamide with Isozyme II and IX
2006
Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease
2012
Neurologist-associated reduction in PD-related hospitalizations and health care expenditures
2012
Hydrogel bioelectronics
2018 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Mitaplatin Increases Sensitivity of Tumor Cells to Cisplatin by Inducing Mitochondrial Dysfunction
2012
PeroralRoute: An Opportunity for Protein and Peptide Drug Delivery
2001
Carbonic Anhydrase Inhibitors: Stacking with Phe131 Determines Active Site Binding Region of Inhibitors As Exemplified by the X-ray Crystal Structure of a Membrane-Impermeant Antitumor Sulfonamide Complexed with Isozyme II
2005
Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
2013
Depressogenic effects of medications: a review
2011
Exhaustive, ONE-YEAR FOLLOW-UP OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A LARGE, SINGLE-CENTER COHORT OF PARKINSONIAN PATIENTS
2007
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Physiotherapy in Parkinson’s Disease: A Meta-Analysis of Present Treatment Modalities
2020
Neuropsychological changes between “off” and “on” STN or GPi stimulation in Parkinson’s disease
2000
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease
2008
Position Statement of the American Association for Geriatric Psychiatry Regarding Principles of Care for Patients With Dementia Resulting From Alzheimer Disease
2006
Phosphine-catalyzed [3 + 2] and [4 + 2] annulation reactions of ynones with barbiturate-derived alkenes
2017
Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts
2018
Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease
2017
Asymmetric Construction of Highly Functionalized Spirobarbiturate‐Cyclopentenes through Chiral Phosphine‐Catalyzed [3+2] Annulation of Morita–Baylis–Hillman Carbonates with Barbiturate‐Derived Alkenes
2016
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor
2003
Deep-Brain Stimulation of the Subthalamic Nucleus or the Pars Interna of the Globus Pallidus in Parkinson's Disease
2001
Rotenone, Paraquat, and Parkinson’s Disease
2011 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Interventions for fatigue in Parkinson's disease
2015
Update of the MDS research criteria for prodromal Parkinson's disease
2019
α‐Synuclein oligomers and clinical implications for Parkinson disease
2012
Works of Kelly E. Lyons being referenced
Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): [RETIRED]
2006
Classification of Parkinson’s disease and essential tremor based on balance and gait characteristics from wearable motion sensors via machine learning techniques: a data-driven approach
2020
Prevalence of Parkinson’s Disease in Bulgarian Gypsies
2000
Deep brain stimulation: Preoperative issues
2006
Benefits and Risks of Pharmacological Treatments for Essential Tremor
2003
Long term safety and efficacy of unilateral deep brain stimulation of the thalamus for parkinsonian tremor
2001
Subthalamic Nucleus Stimulation in Parkinson’s Disease Patients Intolerant to Levodopa
2007
Essential tremor: differential diagnosis and current therapy
2003
Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease
2009
Head injury, alpha‐synuclein Rep1, and Parkinson's disease
2011
Diagnostic Validity of the Dementia Questionnaire for Alzheimer Disease
1998
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease
2013
Preoperative Clinical Predictors of Response to Bilateral Subthalamic Stimulation in Patients with Parkinson’s Disease
2005
The influence of depression on cognition in Parkinson's disease
1995
Efficacy of unilateral deep brain stimulation of the vim nucleus of the thalamus for essential head tremor
1999
Effect of stimulation frequency on tremor suppression in essential tremor
2004
Hospitalization in Parkinson disease: A survey of National Parkinson Foundation Centers
2011
Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations
2011
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
2006 Standout
Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow up
2003
Health-Related Quality of Life in Parkinson's Disease after Pallidotomy and Deep Brain Stimulation
2000
Deep brain stimulation in Parkinson’s disease
2004
Efficacy and Tolerability of Levetiracetam in Parkinson Disease Patients With Levodopa-Induced Dyskinesia
2006
Double‐blind controlled trial of gabapentin in essential tremor
1998
Effects of thalamic deep brain stimulation based on tremor type and diagnosis
1997
Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease
2005
Long-Term Efficacy of Globus pallidus Stimulation for the Treatment of Parkinson’s Disease
2002
Randomized, double‐blind, pilot evaluation of intravenous glutathione in Parkinson's disease
2009
Long‐term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor
2001
Onset of dyskinesia with adjunct ropinirole prolonged‐release or additional levodopa in early Parkinson's disease
2010
Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD)
2010
Deep brain stimulation for Parkinson's disease
2006
Neuropsychological and Quality of Life Changes Following Unilateral Thalamic Deep Brain Stimulation in Parkinson's Disease: A One-Year Follow-up
2001
Early biomechanical markers of postural instability in Parkinson's disease
2009
Effect of Motor Improvement on Quality of Life following Subthalamic Stimulation Is Mediated by Changes in Depressive Symptomatology
2003
Management of the hospitalized patient with Parkinson’s disease: Current state of the field and need for guidelines
2010
Mitochondrial respiration and respiration‐associated proteins in cell lines created through Parkinson’s subject mitochondrial transfer
2010
Pulse width is associated with cognitive decline after thalamic stimulation for essential tremor
2003
Functional correlates of pallidal stimulation for Parkinson's disease
2001
Patient versus informant reporting of ICD symptoms in Parkinson’s disease using the QUIP: Validity and variability
2010
Glucocerebrosidase mutations in diffuse Lewy body disease
2010
Comparison of thalamotomy to deep brain stimulation of the thalamus in essential tremor
2001
Pharmacotherapy of Essential Tremor
2008
Deep Brain Stimulation and Essential Tremor
2004
Factors limiting the oral bioavailability of N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion
2000
Surgical treatment of Parkinson’s disease
1999
Deep brain stimulation: Postoperative issues
2006
Unilateral pallidal stimulation for Parkinson's disease: Neurobehavioral functioning before and 3 months after electrode implantation
1997
Peptidoglycan recognition protein genes and risk of Parkinson's disease
2014
Long-term evaluation of deep brain stimulation of the thalamus
2006
Ropinirole 24-hour prolonged release
2007
Surgical and hardware complications of subthalamic stimulation
2004
MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy
2011
Development and initial validation of a screening tool for Parkinson disease surgical candidates
2004
Neuropsychological and quality of life outcome after thalamic stimulation for essential tremor
1999
Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease
2006
Analysis of Pallidotomy Lesion Positions Using Three-dimensional Reconstruction of Pallidal Lesions, the Basal Ganglia, and the Optic Tract
1997
Advanced Parkinson disease treated with rotigotine transdermal system
2007
High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease
1997
Surgical treatment of essential tremor.
2000
Gender differences in Parkinson's disease.
1998
A comparison of Parkinson's disease symptoms and self-reported functioning and well being
1997
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)
2017
Occupation and risk of parkinsonism: a multicenter case-control study.
2009
Practice parameter: Risk of driving and Alzheimer’s disease (an evidence-based review) [RETIRED]
2000